Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 4361 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

BMS extends AIDS programs assistance

As a result of its decision, Bristol-Myers Squibb will continue to provide to AIDS drug assistance programs (ADAPs) during the next two years by supplying its complete line

CytRx progressing with phase I HIV trial

The primary objective of the three-arm phase I clinical trial is to determine the safety and tolerability of different dosages and routes of administration of the DNA vaccine,

Metabolex drug could advance diabetes treatment

The trial’s primary endpoint was to reduce hemoglobin A1c (HbA1c). The proof-of-principle trial demonstrated that metaglidasen had comparable efficacy to currently marketed insulin sensitizers without causing the dose-limiting

CoTherix’ hypertension drug commercially available

Ventavis (iloprost) is the newest entry into the prostacyclin class of pulmonary arterial hypertension (PAH) treatments. Prior to the introduction of Ventavis, prostacyclin therapies for PAH required continuous